Octave Bioscience is entering into a collaboration with Quest Diagnostics to expand access to its multiple sclerosis disease activity (MSDA) test, which uses data from a set of blood biomarkers to measure how active a patient’s disease is in people with multiple sclerosis (MS). Although the MSDA test became widely available across the U.S. earlier […]
The post Collaboration will make MSDA blood test easier to access in US appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com